Advanced #ProstateCancer Q&A | Eugene Kwon, MD & Mark Moyad, MD MPH | [Video]

Donate to PCRI: https://pcri.org/donate/
For more information, visit https://pcri.org

1:02 The DIY manual for combating Prostate Cancer series
7:57 QR code for DIY Combat Manual for Beating Prostate Cancer Videos
9:07 The different types of Prostate Cancer – Local, Focal, Zonal, Diffuse
11:03 Metastatic Spread of Prostate Cancer
12:47 Clonal Model for Cancer Progression
13:52 Heterogeneous Model for Cancer Progression
15:01 Immunotherapy
16:24 Systemic Treatments 2024
17:50 Directed Therapies 2024
19:18 Regular and Comprehensive Follow Up is Key
21:42 Live Discussion – Fact or Fiction
23:58 Stage 4 Prostate Cancer = “Put your affairs in order?”
31:00 The higher the PSA the more aggressive the cancer
35:40 If my PSA has been undetectable or not moving for years is everything ok?
38:17 Should I ask for a second opinion?
43:23 When an insurance company says “no” is there anything I can do?
54:22 If you’ve had radiation treatment once can you have it again?
56:57 How many people receive spot radiation and later another spot radiation?
1:01:16 With radiation targeting spots is it better for spots close together or spread out?
1:02:32 With reoccurrence what about other treatments other than radiation?
1:05:56 Chemotherapy is rarely needed because of too many side effects? True of False?
1:10:35 How long are you on chemotherapy?
1:12:54 Does chemo therapy work against mutated cancer cells?
1:14:39 Is chemotherapy good for low and high volume disease?
1:20:08 In the era of PET imaging disease is being seen earlier
1:21:10 A lot of times the things you see in a scan aren’t what needs to be worried about
1:21:40 Will Pluvicto get FDA approval for castrate sensitive prostate cancer?
1:25:54 Actinium-225 radioligand therapy possible approval in the next 3 years?
1:33:33 As you get older recovery becomes as important as the actual physical activity
1:34:20 Is Provenge the only approved immune therapy for castrate resistant prostate cancer?
1:35:47 Genetic testing may reveal enough mutations for good response to immune therapy
1:41:32 Melanoma, renal cell carcinoma, bladder cancer, have highest level of mutations
1:43:27 One liquid biopsy is better than no liquid biopsy?
1:47:58 Is PSMA PET/CT scan better than any other type of PET/CT scan?
1:50:30 10-20% of patients will have forms of disease that cannot be seen on PSMA PET scan
1:52:35 Top 5 slide topics

Don’t know your stage? Take the quiz: visit http://www.prostatecancerstaging.org

To learn more about prostate cancer, visit http://www.pcri.org

Sign up for our newsletter here to receive the latest updates on prostate cancer and the PCRI: https://pcri.org/join

Who we are:

The Prostate Cancer Research Institute (PCRI) is a 501(c)(3) not-for-profit organization that is dedicated to helping you research your treatment options. We understand that you have many questions, and we can help you find the answers that are specific to your case. All of our resources are designed by a multidisciplinary team of advocates and expert physicians for patients. We believe that by educating yourself about the disease, you will have more productive interactions with your medical professionals and receive better-individualized care. Feel free to explore our website at pcri.org or contact our free helpline with any questions that you have at pcri.org/helpline. Our Federal Tax ID # is 95-4617875 and qualifies for maximum charitable gift deductions by individual donors.